Need Softgel Services? Sophia can help.

Sophia provides Softgel CDMO Services for sponsors developing prescription medicines, OTC products, nutraceutical-adjacent pharmaceutical products, lipid-based formulations, poorly soluble drugs, hormones, vitamins, specialty capsules, paediatric-friendly formats, lifecycle extension products, and complex oral dose programmes requiring controlled formulation, encapsulation, drying, stability, packaging, and documentation.

Softgels look simple because the patient sees a smooth capsule. The development work behind that capsule is not simple. A softgel is a sealed, flexible dosage form where fill formulation, shell chemistry, moisture, plasticiser, seam formation, drying, migration, oxidation, dissolution, leakage, packaging, and long-term stability all interact. A product can fail because the fill becomes unstable, the shell becomes brittle, the capsule leaks, gelatin crosslinks, drug migrates into the shell, oxygen enters the system, dissolution slows, or the fill attacks the capsule from inside.

That is why Softgel CDMO Services require more than capsule filling. The product is a system: active ingredient, solvent, lipid, surfactant, cosolvent, antioxidant, shell polymer, gelatin or non-gelatin alternative, plasticiser, colourant, opacity system, seam integrity, drying profile, packaging, and storage condition.

Sophia supports softgel programmes through API and fill-formulation review, solubility strategy, lipid and self-emulsifying systems, gelatin shell development, vegetarian shell interface, plasticiser strategy, encapsulation process development, seam and leak testing, drying optimisation, dissolution testing, assay and impurity analytics, microbial quality, stability, packaging compatibility, GMP/GMP-like documentation, and European execution through state-of-the-art facilities in Spain and Switzerland.

The objective is direct: develop softgel products that are elegant to use, stable on shelf, manufacturable at scale, and defensible as pharmaceutical dosage forms.

Why Softgels Matter

Softgels matter because they solve practical problems that ordinary tablets and hard capsules do not always solve well. They can improve delivery of poorly soluble drugs, protect oxidation-sensitive ingredients, contain liquid or semi-solid fills, improve swallowability, support rapid release, reduce dust handling, mask taste or odour, and create a premium patient or consumer experience.

For certain products, the softgel format is not cosmetic. It is functional. Lipophilic APIs may dissolve better in lipid-based fills. Low-dose potent APIs can sometimes be dosed uniformly in liquid fill systems. Volatile or odorous materials may be better contained.

Oxygen-sensitive materials may be paired with antioxidants and protective packaging. Hormones and vitamins may benefit from controlled solubilisation and encapsulation. OTC products may use softgels for fast release, improved mouthfeel, and brand differentiation.

Softgel products are especially relevant for:

• Poorly soluble small molecules
• Lipid-soluble vitamins
• Hormones and steroidal products
• OTC analgesic and cold products
• Gastrointestinal products
• Specialty oral dose programmes
• Nutraceutical-adjacent pharmaceutical products
• Lifecycle extension products
• Paediatric and geriatric-friendly formats
• Liquid-fill oral products
• Self-emulsifying drug delivery systems
• Products needing odour or taste masking

A serious Softgel CDMO Services programme must therefore connect formulation science, shell chemistry, encapsulation process, drying, dissolution, stability, and packaging. The capsule is small. The system is not.

The History of Softgel Dosage Forms

The history of softgel capsules begins with an old pharmaceutical desire: make medicines easier to swallow, easier to dose, and easier to protect. Before modern encapsulation, many medicines were bitter powders, oils, extracts, tinctures, or crude preparations. The patient experience could be unpleasant. The dose could be imprecise. The material could oxidise, spill, smell, separate, or degrade.

Gelatin changed the physical language of dosage forms. Derived from collagen, gelatin could form flexible films, dissolve in biological fluids, and create a protective shell around a fill. Early capsule technology gave pharmacists and manufacturers a way to separate the patient from the unpleasantness of the medicine. The capsule became a civilising technology: a small envelope between chemistry and the mouth.

Soft capsules developed as manufacturers learned to encapsulate liquids and semi-solids inside elastic gelatin shells. The key advance was not simply making a capsule softer. It was creating a sealed dosage form where fill and shell could be manufactured continuously and reproducibly. Rotary die encapsulation later became the defining industrial process: two gelatin ribbons, a fill pump, dies shaping the capsule, and a seam formed around a measured dose. The product looked smooth and effortless. The machinery behind it was precise, mechanical, and quietly brilliant.

The softgel became especially useful as pharmaceutical chemistry produced more lipophilic molecules. Many active ingredients do not behave politely in water. They dissolve in oils, solvents, surfactants, or lipid systems more readily than in simple aqueous media. The softgel allowed these liquid and semi-solid systems to become patient-ready oral dosage forms. It turned formulation problems into capsule products.

The consumer health industry also helped make softgels culturally familiar. Vitamins, oils, analgesics, sleep aids, and OTC products used softgels to signal ease, smoothness, and fast action. That popularity sometimes made softgels seem less technical than tablets. In reality, the opposite is often true. A tablet may be mechanically complex, but a softgel is chemically intimate. The fill and shell live together for the entire shelf life. They exchange water. They exchange plasticiser. They can react, migrate, harden, soften, leak, or fail dissolution.

Modern softgel development now sits between classical pharmaceutics and sophisticated delivery science. It includes lipid-based drug delivery, self-emulsifying systems, vegetarian shell technologies, low-moisture shells, enteric approaches, controlled oxygen exposure, high-potency handling, paediatric-friendly presentations, and global regulatory expectations.

The history is therefore not just “capsules became smoother.” The real history is that the capsule became a miniature controlled environment.

That is the territory for Softgel CDMO Services: small dosage forms with large formulation consequences.

The Material Science of Softgels

A softgel has two main physical components: the fill and the shell. The fill contains the active ingredient and formulation system. The shell contains gelatin or an alternative film-forming polymer, plasticiser, water, colourants, opacifiers, and sometimes additional functional excipients.

The fill may be a solution, suspension, lipid mixture, semi-solid, self-emulsifying system, emulsion-adjacent system, or paste. It may contain oils, triglycerides, medium-chain triglycerides, polyethylene glycol systems, surfactants, cosolvents, antioxidants, suspending agents, viscosity modifiers, or stabilisers.

The shell must be flexible enough to form and survive handling, but strong enough to protect the fill. Gelatin shells commonly use plasticisers such as glycerol or sorbitol to maintain flexibility. Water content is critical. Too much moisture can soften capsules or affect stability. Too little moisture can make shells brittle. Shell pH, bloom strength, viscosity, plasticiser ratio, drying profile, and storage humidity all influence final quality.

The fill and shell interact. Water can migrate from shell to fill or fill to shell. Plasticiser can migrate. API can migrate into the shell. Fill solvents can soften or weaken the shell. Reactive APIs can crosslink gelatin. Aldehydes, peroxides, reducing sugars, and oxidation products can contribute to shell hardening or dissolution slowdown. Oils can oxidise. Surfactants can alter shell integrity.

Softgel development is therefore a compatibility science. The capsule is a small chemical ecosystem.

Softgel Product Types Supported

Sophia supports Softgel CDMO Services across pharmaceutical, OTC, specialty, and nutraceutical-adjacent product categories.

Product types may include prescription softgels, OTC softgels, lipid-based softgels, hormone softgels, vitamin softgels, poorly soluble drug softgels, self-emulsifying softgels, liquid-filled capsules, semi-solid filled softgels, immediate-release softgels, low-dose potent softgels, paediatric-friendly softgels, geriatric-friendly softgels, odour-masked softgels, taste-masked softgels, and specialty oral dose products.

Programme types may include early formulation screening, prototype development, clinical trial material, GMP/GMP-like manufacturing, scale-up, reformulation, lifecycle extension, generic softgel development, technology transfer, packaging studies, stability studies, and commercial-readiness planning.

Softgels may be used for small molecules, vitamins, hormones, oils, lipophilic actives, certain peptide-adjacent oral research formats, and other suitable materials. The format must be selected based on chemistry, dose, stability, solubility, route, market, and regulatory requirements.

A strong Softgel CDMO Services programme begins by asking whether the softgel format genuinely improves the product. If it does, the development path becomes much clearer.

Fill Formulation Development

Sophia supports softgel fill formulation development, including API solubility, vehicle selection, lipid system design, surfactant selection, cosolvent strategy, antioxidant screening, suspension design, viscosity control, fill homogeneity, chemical stability, physical stability, and manufacturability.

Fill formulation is often the main reason a softgel exists. If the API is poorly soluble, the fill must keep it dissolved or dispersed consistently. If the API is oxidation-sensitive, the fill may need antioxidant protection, low-peroxide excipients, nitrogen blanketing, or protective packaging. If the API is low-dose, the fill must maintain uniform distribution. If the API is suspended, particle size and sedimentation must be controlled. If the API is lipophilic, lipid digestion and dispersion may affect performance.

Common fill approaches may include:

• Lipid solutions
• Oil suspensions
• PEG-based systems
• Self-emulsifying systems
• Self-microemulsifying systems
• Semi-solid fills
• Wax or paste systems
• Surfactant-rich systems
• Antioxidant-protected fills

The fill must also be compatible with encapsulation. It needs suitable viscosity, pumpability, temperature tolerance, low air entrapment, and no destructive interaction with the shell.

A beautiful fill that cannot be encapsulated is not a softgel formulation. It is a lab mixture.

Lipid-Based and Self-Emulsifying Systems

Softgels are especially useful for lipid-based and self-emulsifying drug delivery systems. Sophia supports lipid excipient screening, oil selection, surfactant and cosurfactant strategy, digestion-aware development, dispersion testing, precipitation risk, dilution behaviour, capsule compatibility, and stability.

Lipid-based systems can improve apparent solubility and support absorption of poorly soluble drugs. Self-emulsifying systems disperse when exposed to gastrointestinal fluids, forming emulsions or microemulsions that may improve drug presentation. These systems require careful balance. Too much surfactant may create tolerability or shell compatibility problems. Poor dilution behaviour may cause precipitation. High drug loading may look stable in the capsule but fail during digestion or release testing.

Lipid excipient quality matters. Peroxide levels, acid value, water content, impurities, and supplier variability can affect stability. Oils can oxidise. Surfactants can degrade. Drug can precipitate over time. Shell interactions can change dissolution.

Lipid softgels are powerful when designed properly. When designed casually, they become little capsules of future instability.

Shell Development: Gelatin and Vegetarian Systems

Sophia supports gelatin and non-gelatin shell development for softgel products. Shell strategy may include gelatin type, bloom strength, viscosity, plasticiser system, water content, colour, opacity, preservatives where appropriate, vegetarian shell polymers, starch or carrageenan systems, HPMC-adjacent technologies, and low-moisture shell approaches.

Gelatin remains the classical softgel shell material because it forms strong, elastic films and works well in rotary die encapsulation. But gelatin is animal-derived, moisture-sensitive, and vulnerable to crosslinking. Sponsors may prefer non-gelatin shells for dietary, religious, market, stability, or branding reasons.

Vegetarian softgels can support broader market access, but they also bring technical constraints. Non-gelatin shells may require different processing temperatures, drying behaviour, mechanical properties, seam formation, dissolution profiles, and fill compatibility. They are not simple drop-in replacements for gelatin.

Shell development must match the fill. PEG-rich fills, aldehyde-generating fills, hygroscopic fills, low-pH fills, high-surfactant fills, or volatile fills may challenge shell integrity. The shell has to hold the medicine without becoming part of the problem.

Encapsulation Process Development

Sophia provides Softgel CDMO Services for encapsulation process development, including fill preparation, gelatin mass preparation, ribbon casting, temperature control, fill pumping, die selection, seam formation, capsule size, capsule shape, fill weight, ribbon thickness, lubrication, in-process controls, drying transfer, and defect reduction.

Rotary die encapsulation is the central softgel manufacturing process. Two ribbons of shell material are formed, the fill is injected between them, and rotating dies shape and seal capsules. The process looks continuous, but many variables must align.

Critical process factors may include:

• Gelatin mass viscosity
• Ribbon thickness
• Ribbon temperature
• Fill viscosity
• Fill temperature
• Pump accuracy
• Die condition
• Seam thickness
• Capsule size and shape
• Fill weight uniformity
• Lubricant control
• Drying conditions

Defects may include leaking capsules, weak seams, air bubbles, misshapen capsules, fill-weight variability, shell thinning, sticking, rough surfaces, twin capsules, and drying deformation. Process development aims to reduce these defects while preserving product quality.

Softgel encapsulation is a mechanical art with pharmaceutical consequences.

Drying, Curing, and Moisture Control

After encapsulation, softgels require drying. Sophia supports drying and curing development, including tumble drying, tray drying, humidity control, temperature control, airflow, drying time, residual moisture, shell hardness, capsule deformation, sticking, brittleness, and stability.

Drying removes excess water from the shell and gives the capsule final mechanical properties. Too much residual moisture can make capsules soft, sticky, unstable, or prone to microbial risk. Too little moisture can make shells brittle or crack. Uneven drying can create deformation or stress. Overly aggressive drying can damage the shell or fill.

Moisture also affects dissolution and stability. Gelatin shells can harden over time, especially under certain chemical stresses. Fill ingredients can absorb or donate water.

Packaging must maintain the intended moisture environment.

Drying is not a housekeeping step. It is where the capsule becomes physically real.

Dissolution, Disintegration, and Bioavailability

Sophia supports dissolution, disintegration, dispersion, and performance testing for softgel products. Testing strategy depends on drug solubility, fill type, shell material, intended release profile, and regulatory path.

Softgels can dissolve rapidly, but they can also create testing challenges. Gelatin crosslinking may slow dissolution. Lipid fills may require enzymes, surfactants, biorelevant media, or digestion-aware methods. Suspended drugs may show dissolution dependent on particle size. Self-emulsifying systems may require dispersion testing. Vegetarian shells may behave differently from gelatin.

Bioavailability performance depends on whether the drug remains dissolved, disperses properly, avoids precipitation, and is presented to absorption sites effectively. For poorly soluble drugs, the in vitro method should be meaningful enough to detect formulation changes.

A softgel that passes appearance testing but fails dissolution is not a stable product. It is a smooth-looking problem.

Analytics and Quality Control

Sophia’s Softgel CDMO Services include analytical development for assay, content uniformity, fill weight, dissolution, disintegration, impurity profile, degradation products, residual solvents, water content, peroxide value where relevant, microbial quality, capsule shell properties, leak testing, seam integrity, appearance, colour, odour, hardness, elasticity, and stability.

Methods may include HPLC, UPLC, LC-MS, GC, GC-MS, Karl Fischer water testing, dissolution testing, disintegration testing, microscopy, viscosity testing, peroxide testing, microbial limits, elemental impurities where relevant, and product-specific stability-indicating methods.

Softgel analytics must account for the fill and shell. The active may be in the fill, but the shell can affect release, stability, and appearance. Fill extraction must be validated. Shell interference must be managed. Low-dose products may require careful sample preparation. Lipid matrices may complicate chromatography. Suspensions may need homogeneity controls.

Quality control must be built around the dosage form as it actually exists: flexible capsule, complex fill, interactive shell.

Stability and Packaging

Sophia supports stability and packaging development for softgel products, including long-term stability, accelerated stability, photostability, humidity exposure, oxidation, capsule brittleness, leakage, dissolution slowdown, fill degradation, shell crosslinking, microbial quality, blister packaging, bottle packaging, desiccants, oxygen absorbers, nitrogen headspace, light protection, and cold-chain or controlled-room-temperature planning.

Softgels are sensitive to packaging. Moisture exposure can soften shells. Dry conditions can embrittle them. Oxygen can oxidise lipid fills. Light can degrade sensitive actives. Heat can increase migration, leakage, or shell deformation. Packaging must protect the capsule’s physical and chemical balance.

Blisters may provide unit-dose protection. Bottles may be cost-effective but expose capsules to repeated humidity and oxygen after opening. Desiccants may help some products and harm others if they over-dry shells. Oxygen absorbers may benefit oxidation-sensitive fills. The packaging system should be selected through data, not habit.

A softgel’s shelf life is a negotiation between formulation, shell, package, and climate.

A Focused Development Checklist

For softgel programmes, Sophia helps sponsors define the product route early:

• Is the active best suited to a solution, suspension, lipid, or semi-solid fill?
• Is gelatin or a vegetarian shell more appropriate for the market and chemistry?
• What fill-shell interactions create stability risk?
• What dissolution method reflects product performance?
• What packaging protects moisture, oxygen, light, and capsule integrity?

These questions prevent late-stage failure. Softgels often look finished before they are actually stable.

GMP, CMC, and Regulatory Documentation

Sophia supports GMP/GMP-like and CMC documentation for Softgel CDMO Services, including formulation development reports, fill composition, shell composition, process description, encapsulation parameters, drying profile, in-process controls, analytical methods, specifications, dissolution method, stability protocol, packaging justification, batch records, CoA, deviation handling, change control, comparability, and tech transfer package.

CMC documentation must explain why the fill formulation was selected, how shell compatibility was demonstrated, how encapsulation is controlled, how drying is managed, how dissolution is tested, how impurities are monitored, how packaging protects the product, and how stability supports shelf life.

For softgels, the dossier should describe the dosage form as an integrated system. Fill, shell, process, and package are inseparable.

A serious softgel CMC package makes a smooth capsule scientifically legible.

Why Sophia for Softgel CDMO Services

Sophia supports softgel programmes through formulation development, shell strategy, encapsulation process control, analytical development, stability testing, packaging evaluation, European facility execution, and GMP/GMP-like documentation.

The service includes:

• Softgel programme review
• Poorly soluble drug formulation
• Lipid-based and self-emulsifying systems
• Solution, suspension, semi-solid, and paste fills
• Gelatin and vegetarian shell development
• Plasticiser and moisture strategy
• Rotary die encapsulation process development
• Drying, curing, and residual moisture control
• Dissolution and disintegration testing
• Leak, seam, appearance, and fill-weight controls
• Oxidation, crosslinking, and shell compatibility assessment
• Packaging and stability development
• Spain and Switzerland-linked European execution
• GMP/GMP-like documentation
• Global tech transfer support

The platform is suited to sponsors who need softgel products that are stable, attractive, manufacturable, analytically controlled, and ready for pharmaceutical development.

Technical Service Summary

Sophia provides Softgel CDMO Services for prescription softgels, OTC softgels, lipid softgels, poorly soluble drug softgels, vitamin softgels, hormone softgels, self-emulsifying systems, semi-solid fills, suspension fills, vegetarian softgels, gelatin softgels, lifecycle extension products, and complex oral dose programmes.

Relevant technical needs include fill formulation, shell development, encapsulation, drying, dissolution, disintegration, assay, impurity testing, water content, peroxide testing, leak testing, seam control, packaging, stability, GMP/GMP-like documentation, and global tech transfer.

The service is intended for products where fill chemistry, shell behaviour, encapsulation quality, packaging, and shelf-life performance define success.

Read More About Related Sophia Capabilities

Prebiotic Skincare CDMO Services
Prebiotic skincare products require ingredient strategy, mild formulation, barrier support, preservation, stability, and claims-aware positioning.

Postbiotic Skincare CDMO Services
Postbiotic skincare products use non-live microbial materials, lysates, ferments, and metabolites requiring stability and quality control.

PDRN Skincare CDMO Services
PDRN and retinoid skincare products may support advanced beauty positioning, post-procedure cosmetic routines, stability control, and claims discipline.

Scalp Cosmetic CDMO Services
Retinoid-adjacent scalp products require tolerability, low residue, clean sensory feel, stability, and careful cosmetic positioning.

FAQ: Softgel CDMO Services

1. What are Softgel CDMO Services?

Softgel CDMO Services support formulation, encapsulation, drying, testing, stability, packaging, documentation, and manufacturing strategy for soft gelatin or non-gelatin capsule products.

2. What products are suitable for softgels?

Softgels are often suitable for poorly soluble drugs, lipid-soluble actives, vitamins, hormones, OTC products, liquid fills, semi-solid fills, and products needing taste or odour masking.

3. What is inside a softgel?

A softgel usually contains a liquid, suspension, semi-solid, lipid, oil, PEG-based, or self-emulsifying fill enclosed in a flexible gelatin or non-gelatin shell.

4. Can Sophia support vegetarian softgels?

Yes. Sophia supports vegetarian and non-gelatin shell development, including shell compatibility, processing behaviour, dissolution, stability, and market-specific requirements.

5. Why do softgels fail stability?

Softgels may fail due to fill degradation, oxidation, shell brittleness, shell softening, leakage, gelatin crosslinking, drug migration, dissolution slowdown, or packaging-related moisture and oxygen exposure.

6. What analytics are used for softgels?

Analytics may include assay, impurities, dissolution, disintegration, fill weight, water content, peroxide value, residual solvents, microbial limits, leak testing, seam integrity, appearance, and stability testing.

7. Can softgels improve bioavailability?

Softgels can improve presentation of poorly soluble drugs when lipid, solvent, or self-emulsifying systems keep the drug dissolved or dispersed appropriately. Product-specific testing is required.

8. What is rotary die encapsulation?

Rotary die encapsulation is a softgel manufacturing process where two shell ribbons are formed around a measured fill and sealed into capsules using rotating dies.

9. How important is packaging for softgels?

Packaging is critical because softgels are sensitive to moisture, oxygen, light, and heat. Blisters, bottles, desiccants, oxygen absorbers, and light protection may be evaluated.

10. What should sponsors provide to begin a softgel project?

Useful starting information includes API properties, dose, solubility, stability data, target market, desired shell type, fill preferences, dissolution goals, packaging preferences, and development stage.

Conclusion

Sophia provides Softgel CDMO Services for pharmaceutical and specialty oral dose products where fill, shell, encapsulation, drying, packaging, and stability must work together.

Softgel development requires more than smooth capsule appearance. It requires controlled formulation, fill-shell compatibility, dissolution performance, moisture control, oxidation management, and GMP/GMP-like documentation.

Through state-of-the-art infrastructure in Spain and Switzerland, Sophia supports sponsors from early formulation through encapsulation development, stability, packaging, CMC documentation, and global tech transfer.

Email our team at info@sophiacdmo.com